NCT05169697
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05169697
Title A Study to Assess YH002 in Combination With YH001 in Subjects With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Eucure (Beijing) Biopharma Co., Ltd
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
Orange Health Services Orange New South Wales 2800 Australia Details
Macquarie University Hospital Sydney New South Wales 2109 Australia Details
Peninsula and South Eastern Haematology & Oncology Group Frankston Victoria 3199 Australia Details
Cabrini Hospital Malvern Malvern Victoria 3144 Australia Details
Henan Tumor Hospital Zhengzhou Henan 450008 China Details
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan Hubei 430022 China Details
Liaoning Cancer Hospital Shenyang Liaoning 110801 China Details
Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai Shanghai Municipality 200020 China Details
Sir Run Run Shaw Hospital Hangzhou Zhejiang 310020 China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field